Effect of Polyunsaturated Fatty Acids on Homocysteine Metabolism through Regulating the Gene Expressions Involved in Methionine Metabolism

Table 2

Changes of plasma phospholipids fatty acids in rats after supplementations.

PL fatty acids, %	CC	18:1	22:6𝑛-3	20:5𝑛-3	18:3𝑛-3	18:2𝑛-6	CLA	SO
18:1𝑛-9	6.62±0.32	10.40±0.34	7.84±0.31	8.30±0.32	7.93±0.36	11.21±0.31	10.50±0.30	9.84±0.31
18:1𝑛-7	1.06±0.67	1.12±1.69	0.91±0.66	1.05±0.67	0.77±0.71	0.92±0.22	0.92±0.21	0.91±0.16
18:2𝑛-6	27.89±3.87	26.63±3.89	24.22±3.86	27.33±3.87	24.82±3.91	28.29±3.50	32.94±3.49	28.52±2.86
18:3𝑛-6	0.82±0.12	1.13±0.16	2.01±0.13	1.52±0.14	0.90±0.23	0.65±0.14	0.48±0.13	0.91±0.13
18:3𝑛-3	0.83±0.16	0.96±0.08	0.90±0.05	0.83±0.06	1.23±0.19	0.93±0.07	1.12±0.07	0.90±0.15
20:00	1.12±0.11	1.03±0.16	2.13±0.13	1.78±0.14	0.93±0.23	0.77±0.14	0.15±0.17	1.13±0.13
20:1𝑛-9	0.30±0.17	0.28±0.19	0.38±0.16	0.50±0.17	0.25±0.21	0.24±0.17	0.51±0.16	0.31±0.16
20:2𝑛-6	0.82±0.61	0.86±0.62	1.78±0.59	0.98±0.6	0.71±0.69	0.55±0.56	0.39±0.55	0.78±0.25
20:3𝑛-6	0.30±0.99	0.30±2.01	0.37±1.98	0.30±1.99	0.25±0.08	0.19±1.81	0.35±1.80	0.77±1.91
20:4𝑛-6	29.11±3.80	25.43±3.83	22.78±3.81	22.75±3.8	27.08±3.91	23.53±3.45	20.11±3.44	24.78±4.81
20:5𝑛-3	0.89±2.87	0.64±2.90	1.20±2.87	1.61±2.87	0.71±2.97	0.29±0.61	0.17±2.60	1.21±0.92
22:1𝑛-9	1.13±1.03	0.89±1.06	0.80±1.03	1.98±1.03	0.99±0.13	0.48±0.95	1.51±0.94	0.97±0.13
22:2𝑛-6	0.89±0.25	0.64±0.30	1.33±0.27	1.98±0.25	0.99±0.27	0.48±0.27	1.51±0.26	1.13±0.21
22:4𝑛-6	0.39±0.52	0.37±0.57	0.52±0.54	0.43±0.53	0.78±0.52	0.18±0.51	0.28±0.50	0.42±0.55
22:5𝑛-6	0.42±0.27	0.32±0.31	0.90±0.28	0.91±0.27	0.66±0.21	0.17±0.28	0.14±0.27	0.72±0.27
22:5𝑛-3	0.83±0.51	0.71±0.63	0.56±0.62	0.80±0.59	0.71±0.58	0.27±0.57	0.78±0.56	0.52±0.72
22:6𝑛-3	3.86±1.42	4.53±1.44	5.87±1.41	5.36±1.4	5.27±1.39	3.47±1.30	4.76±1.29	5.81±2.40
SFA	3.46±3.23	24.29±3.67	24.96±3.64	28.13±3.63	25.07±3.62	26.27±3.30	27.57±3.29	24.67±5.67
MUFA	9.53±5.38	9.53±5.33	13.15±5.33	10.77±5.28	12.42±5.28	10.60±4.80	13.90±4.79	13.25±2.13
PUFA	67.07±4.61	62.52±4.69	62.43±4.66	64.49±4.65	64.13±4.61	59.01±4.22	63.03±4.21	64.41±6.61
𝑛-3 PUFA	6.42±3.71	6.85±3.25	8.51±3.22	8.30±3.21	7.93±3.2	4.96±2.93	6.84±2.92	7.51±1.21
𝑛-6 PUFA	60.64±3.41	55.68±3.95	53.91±3.92	56.19±3.91	56.19±3.9	54.05±3.56	56.19±3.55	54.91±5.92
𝑛-3:𝑛-6	0.11±0.09	0.12±0.09	0.16±0.06	0.15±0.05	0.14±0.12	0.09±0.08	0.12±0.07	0.14±0.16

Sample size in each group: 𝑛=10, data was expressed as mean ± SD. CC: control group; CLA: conjugated linoleic acid; SO: stearolic acid. SFA: saturated fatty acids, MUFA: monounsaturated fatty acids, PUFA: polyunsaturated fatty acids; PL: phospholipids.